Background. Enterohemorrhagic Escherichia coli (EHEC) O26 causes diarrhea and hemolytic uremic syndrome (HUS). Strains harboring the stx 1a gene prevail, but strains with stx 2a as the sole Shiga toxin-encoding gene are now emerging. The traits and virulence of the latter set of strains are unknown. We correlated stx genotypes of 272 EHEC O26 strains isolated in 7 European countries between 1996 and 2012 with disease phenotypes. We determined phylogeny, clonal structure, and plasmid gene profiles of the isolates and portray geographic and temporal distribution of the different subgroups.
no significant difference in the long-term outcome of HUS caused by non-O157 EHEC (including EHEC O26) and EHEC O157 [19] . Children suffering from HUS caused by EHEC O26 and other non-O157 EHEC strains are younger than those with HUS caused by EHEC O157:H7 [3, 10] .
Thrombotic microangiopathy caused by Shiga toxins (Stx), the major virulence factors of EHEC, forms the histopathological basis of HUS [1] . EHEC O26:H11/H − produces, singly or together, Stx1a and Stx2a encoded by stx 1a and stx 2a genes, respectively [20] . Most EHEC O26 strains isolated from patients harbor stx 1a only [9, 11, 12, 14, 15, 21] , but strains possessing stx 2a as the sole stx gene, which were first identified in Germany in the mid-1990s [22] , have been increasingly detected throughout Europe [5, 8, 18, [23] [24] [25] and the New World [11, 14] . However, characteristics of such isolates and their potential to cause HUS compared to that of EHEC O26 with other stx genotypes have not been systematically studied. Here we correlated clinical outcomes of the infection with stx genotypes of EHEC O26 isolates, determined the isolates' phylogeny and clonal structure, and portray geographic and temporal distribution of the different subgroups in different European countries.
METHODS

Strains and Patients
Two hundred seventy-two EHEC O26:H11/H − strains were isolated between January 1996 and September 2012 from stools of epidemiologically unrelated patients with HUS (n = 127), bloody diarrhea (n = 18), or nonbloody diarrhea (n = 127) in Germany (n = 182), Austria (n = 38), Italy (n = 24), the Czech Republic (n = 18), Belgium (n = 7), the United Kingdom (n = 2), and Slovakia (n = 1). Demographic characteristics of the patients are provided in Table 1 .
Case Definitions
Diarrhea was defined as 3 or more liquid stools without visible blood per day, and as bloody if blood was visible by the naked eye. The information about the number of stools per day, stool consistency, presence of mucus and/or visible blood, and duration of diarrhea was obtained from treating physicians or patients' parents or guardians using standardized questionnaires. The questionnaires were reviewed nonanonymously by laboratory staff. HUS was defined by a hematocrit level of <30%, with smear evidence of intravascular hemolysis, thrombocytopenia ( platelet count <150 000/mm 3 ), and renal insufficiency (serum creatinine concentration greater than the upper limit of the normal range for age) [1] . Clinical diagnoses based on the case definitions were provided for all patients by treating physicians.
Genotypic and Phenotypic Characterization of EHEC O26 Isolates
Isolates were verified as E. coli (API 20 E; bioMérieux, Marcy l'Etoile, Lyon, France) and O:H serotyped [26] . H types were confirmed using fliC genotyping [7] ; all strains, both motile and nonmotile, possessed the fliC gene encoding the H11 antigen. All stx genotypes, presence of eae (encoding adhesin intimin), and plasmid genes were determined using polymerase chain reaction (PCR) [20, 22] . Stx production was confirmed by Vero cell assay [26] .
Multilocus Sequence Typing
Multilocus sequence typing (MLST) was built on sequences of 7 housekeeping genes [7] , and sequence types (STs) were assigned (http://mlst.ucc.ie/mlst/dbs/Ecoli).
Pulsed-Field Gel Electrophoresis
Pulsed-field gel electrophoresis (PFGE) was performed using the standardized PulseNet protocol [27] with a subset of geographically and temporally representative strains. Restriction patterns were analyzed and the cluster analysis was performed with BioNumerics software, version 6.5 (Applied Maths BVBA, Sint-Martens-Latem, Belgium). The dendrogram was generated using the band-based Dice similarity coefficient (1% band position and 1% optimization tolerance) and the unweighted pair group method with arithmetic means.
Antimicrobial Susceptibility Testing
Susceptibility to ampicillin, cefuroxime, cefotaxime, cefpodoxime, ceftazidime, piperacillin/tazobactam, tigecycline, meropenem, gentamicin, amikacin, trimethoprim/sulfamethoxazole, ciprofloxacin, fosfomycin, and nitrofurantoin was tested using the disk diffusion method according to EUCAST (European Committee on Antimicrobial Susceptibility Testing) breakpoints [28] and standard recommendations [29] .
Statistical Analysis
Statistical analysis was performed using χ Table 2 ). Thus, EHEC O26:H11/H − strains harboring stx 1a alone or in combination with stx 2a are phylogenetically positioned in the same genetic background (as defined by MLST core genome genes), whereas strains with stx 2a but not stx 1a consist of 2 distinct but closely related phylogenetic groups. Of these 2 groups characterized by ST21 and ST29, ST29 and its 2 SLVs (ST396 and ST1566) and ST591 (SLV of ST21) are unique for such strains (Table 3) .
Plasmid Gene Profiles
We plasmid genotyped stx 2a -harboring EHEC O26:H11/H − strains belonging to different STs to provide deeper characterization, with emphasis on the presence of the unique plasmid gene combination found previously in the new stx 2a -harboring EHEC O26 German clone [22] . (Table 4 ). This combination was also found in 2 strains of ST29 and single strains of STs 396 and 591 (Table 4) . Two strains of ST29 and the single ST1566 strain had none of the plasmid genes sought (Table 4) . Thus, based on the phylogeny and plasmid gene profiles, stx 2a -harboring EHEC O26 consists of 2 major subgroups: (i) strains of ST29, which typically contain EHEC-hlyA and etpD, but not espP and katP, and belong to the new EHEC O26 German clone, and (ii) strains of ST21, which differ phylogenetically and by plasmid gene profiles from strains of ST29. Both groups showed a significant risk of progression of the infection to HUS (ST21: OR, 3.4; 95% CI, 1.9-6.0; P < .001; ST29: OR, 9.0; 95% CI, 4.5-17.9; P < .001; Table 2 ). Although ST29 had a 2.6-fold higher OR in terms of HUS association than ST21, there was no statistically significant difference between these 2 STs in their association with HUS (OR, 2.2; 95% CI, 1.0-4.9; P = .089; (Figure 1 ). Cluster A was comprised of all 16 ST21 strains and the single ST591 isolate, with a 78% total similarity ( Figure 1 ). ST29 strains belonged to clusters B (n = 28) and C (n = 13). The similarity between and within clusters B and C was 80%, and 84% and 86%, respectively ( Figure 1) . Thus, strains of ST29 (the new clone) were more closely related to each other than were strains of the other STs. Intriguingly, within each of clusters B and C there were strains with closely related (similarity >95%) or even identical PFGE patterns despite their recovery in different years and/or in different countries (Figure 1 ). The PFGE data suggest the clonal origin of ST29 strains and demonstrate that the new Strains total  65  56  7  3  5  3  139 Abbreviations: +, gene present; -, gene absent; EHEC, enterohemorrhagic Escherichia coli; ST, sequence type. a Presence of the plasmid genes EHEC-hlyA, katP, espP, and etpD (encoding EHEC hemolysin, catalase-peroxidase, serine protease EspP, and type II secretion system, respectively) was determined using polymerase chain reaction. b Plasmid gene profile typical for the new EHEC O26 German clone [22] . Table 2 ). The dendrogram was created by unweighted pair group method with arithmetic means in BioNumerics software 6.5 (Dice similarity coefficient; positional tolerance settings were as follows: optimization 1%; tolerance 1%; H>0%; S>0%); to design patterns, any discernible band difference was considered according to the criteria of PulseNet EHEC O26 clone is highly conserved, in accordance with its recent emergence [22] .
Geographic and Temporal Distribution of EHEC O26 ST29 Strains
EHEC O26 ST29 strains were recovered in 6 of the 7 countries (Table 5) , and in all but 1 study years ( Figure 2 ). There were considerable interannual variations in the relative proportion of ST29 strains among all stx 2a -harboring EHEC O26 ( Figure 2A ) and in spatial distribution of such isolates ( Figure 2B ). Whereas in Germany ST29 strains were isolated during the entire study period (except 2001), their isolation in the other countries was intermittent ( Figure 2B ).
Antibiotic Susceptibilities of stx 2a -harboring EHEC O26 of Different STs
Twenty-three ST29 strains and 11 strains of the other STs selected to span the entire study region and period were tested for their susceptibility to 14 antimicrobials. Twenty ST29, 7 ST21, and 1 each ST396, ST591, and ST1566 strains were susceptible to all tested antimicrobials. One ST21 strain was resistant to ampicillin, cefuroxime, cefpodoxime, tazobactam/ piperacillin, and trimethoprim/sulfamethoxazole and had intermediate susceptibility to cefotaxime. The 3 remaining ST29 strains were resistant to ampicillin (n = 2; one of them had intermediate susceptibility to tigecycline and ciprofloxacin) or to amikacin (n = 1). Hence, there was no correlation between STs and antimicrobial resistance patterns.
DISCUSSION
EHEC O26:H11/H
− are globally emerging human pathogens.
They accounted for 5%-7% of all human EHEC isolates and for 15%-19% of HUS-associated EHEC isolates reported to the European Surveillance System of the European Centre for Disease Prevention and Control between 2008 and 2010, following in frequency EHEC O157 [30, 31] . In the countries participating in this study, EHEC O26 accounted for 16%-55% of EHEC isolates from HUS patients between 2008 and 2012, being in some countries and years the most common cause of pediatric HUS [32] (authors' unpublished data). We now demonstrate that EHEC O26 strains harboring stx 2a as the sole stx have a significant potential to cause HUS, and those harboring both stx 1a and stx 2a have equal potential to cause HUS and diarrhea without HUS, based on analysis of the available clinical isolates. The strong association of the stx 2a genotype in the EHEC O26 infecting strains with the progression of the infection to HUS is in accordance with data from other EHEC series [3, 5, 8, 11] . This study extends our current knowledge about this serotype by demonstrating that stx 2a -harboring EHEC O26 are heterogeneous, consisting of 2 major phylogenetically distinct subgroups (ST21 and ST29), each of which is associated with a particular plasmid gene profile. ST29 strains represent a highly virulent clone of EHEC O26:H11/H − which emerged in Germany in the mid-1990s [22] , and appear to have spread throughout Europe. However, we do acknowledge that this analysis depends on strain recovery practices, and cannot be considered to be a population-based survey. We wish to note that stx 2a -harboring EHEC O26 of ST21 and ST29 do not substantially differ in their association with HUS (Table 2) . Thus, the presence of stx 2a rather than ST of the EHEC O26 isolate is a predictor for HUS development in infected individuals. Why is stx 2a -harboring EHEC O26 a successful clone? We speculate that the ability of EHEC O26 of the new clone to lose the stx 2a -harboring bacteriophage [33] might contribute to its evolutionary success. The lysogenic state is potentially suicidal because it makes the bacterium prone to lysis by stimuli present in its environment, including the human digestive system. Therefore, the absence of the stx-phage might not only increase the adaptability of the pathogens outside the host, but also enable them to avoid lysis in the human gut. Such stx-negative EHEC O26 variants then represent suitable targets for lysogenization by stx-harboring phages released from other EHEC during infection, which could facilitate emergence of highly virulent EHEC O26. Thus, interconversion between EHEC O26 and their stx-negative variants, mediated by recycling stx 2a genes via loss and gain of bacteriophages [33, 34] , might abet the emergence of highly pathogenic new clones of EHEC O26. Although a similar scenario has been proposed for the emergence of the EHEC O104:H4 2011 outbreak strain [35] , the new EHEC O26 clone and the O104:H4 outbreak strain are clearly distinct pathogens, which share the ability to cause HUS, albeit in different age groups (as shown in the current study) [35] . The distinct virulence potentials of EHEC O26 harboring stx 1a and stx 2a , respectively, offer clinical opportunities. In particular, rapid stx genotyping of EHEC O26 isolates from patients with diarrhea might define risk of progression of the disease to HUS and provide a rationale for further management of patients infected with stx 2a -harboring EHEC O26 similarly, as is recommended for patients infected with EHEC O157:H7 [1, 36, 37] . However, because EHEC O26 harboring stx 1a or stx 1a and stx 2a can also cause HUS (Table 2) [5, 7, 17, 22, 25] , individual analysis of each particular case based on clinical parameters is necessary for a final decision about the therapeutic approach. Also, the possibility exists that ex vivo or in-host loss of the stx 2a gene [33, 34] could inappropriately cause an isolate to be categorized as low risk. In this context we wish to note that although we analyzed typical stxharboring EHEC O26, this fact is unlikely to bias our results toward an increased significance of the new clone, because the stx 2a loss, which we observed in our previous studies [33, 34] occurred in EHEC O26 of ST29. Hence, the emerging role of the new clone in HUS might be rather underestimated in our study. Furthermore, it is unlikely that coinfection with another EHEC, in particular EHEC O157, influenced the disease outcome, specifically HUS development in patients with EHEC O26. Only 5 of 272 patients (1.8%) had an additional EHEC strain (1 of them O157) in their stools, and these strains were equally distributed among patients with HUS (n = 2) and uncomplicated diarrhea (n = 3).
Although therapeutic strategies should primarily rely on the presence of the stx 2 genotype as a general risk factor for HUS development, the identification of an EHEC O26 isolate as a member of the new clone is urgent for infection control measures. For this purpose, MLST to determine ST29 is required, in addition to stx subtyping. To accelerate the diagnosis of EHEC O26 ST29, we are developing a real-time multiplex PCR for a rapid and specific detection of this pathogen. Importantly, because ST29 strains have no typical antibiotic resistance pattern, this characteristic cannot be used to identify the new clone. It should be kept in mind that although most EHEC O26 isolates in this study were susceptible to a broad spectrum of antimicrobials, these agents are generally not recommended for treatment of patients with confirmed or suspected EHEC infections because there is no credible evidence that antimicrobials avert HUS, and there are considerable data in support of these agents increasing the risk of this adverse outcome [37] .
Interannual variation in recovery of strains of the new clone might reflect varying exposure of the population to a source/ reservoir of these organisms. Cattle, a major reservoir of EHEC, are also reservoirs for EHEC O26 [25, 38, 39] , but EHEC O26 harboring stx 2a only and/or belonging to ST29 have only rarely been isolated from cattle [23, 25, 39] . Moreover, such strains have only rarely been identified in food [23] , making the risk analysis for acquiring infections caused by stx 2a -harboring EHEC O26 difficult, although some limited data do suggest a bovine source [23] . Improved knowledge about the source of these infections, requiring a close collaboration between public health agencies, veterinary microbiologists, and food safety authorities should facilitate specific infection prevention practices.
In conclusion, in this largest study analyzing the role of EHEC O26 as a human pathogen, we identified the new EHEC O26 clone first found in Germany in the 1990s as an emerging cause of HUS in Europe. These data should prompt efforts to identify reservoirs and sources of these pathogens and to implement rapid diagnostic approaches for their detection.
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